| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Bios Equity Cof, LP serves as a Director, 10% Owner at ACTU. Across recent SEC filings that breaks down to 3 buys and 3 sells. Those positions are worth an estimated $1.4M at current prices.
The biggest single holding is ACTU (~$1.4M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 546,429 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | -71.8% | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | -133.3% | -1.4% | -10.2% | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -16.0% | -1.4% | -10.2% |